Bayawa, Kyle Jesper R.

HRN: 21-15-35  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/21/2024
12/05/2024
PO
4ml
TID
Amoebiasis
Waiting Final Action 
11/21/2024
AMOXICILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
11/21/2024
12/05/2024
PO
2ml
TID
H. Pylori Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: